Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,718 | -9,954 | -9,297 | -3,488 | -1,158 |
| Depreciation Amortization | 199 | 781 | 306 | 146 | 157 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1 |
| Accounts payable and accrued liabilities | -346 | -236 | 299 | -79 | 346 |
| Other Working Capital | -633 | 667 | 579 | -1,485 | 596 |
| Other Operating Activity | 679 | 428 | 372 | 540 | -450 |
| Operating Cash Flow | $-7,820 | $-8,314 | $-7,742 | $-4,367 | $-509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -307 | -704 | -1,199 | -24 | N/A |
| Investing Cash Flow | $-307 | $-704 | $-1,199 | $-24 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,000 | N/A | N/A | -290 | 270 |
| Debt Issued | N/A | N/A | N/A | 4,500 | N/A |
| Debt Repayment | -5 | -5 | -1 | N/A | N/A |
| Common Stock Issued | 10,225 | 1,177 | 29 | 18,888 | N/A |
| Other Financing Activity | -2,000 | -61 | -20 | -572 | 1,055 |
| Financing Cash Flow | $10,220 | $1,112 | $8 | $22,526 | $1,325 |
| Beginning Cash Position | 2,209 | 10,115 | 19,048 | 912 | 96 |
| End Cash Position | 4,302 | 2,209 | 10,115 | 19,048 | 912 |
| Net Cash Flow | $2,093 | $-7,907 | $-8,933 | $18,135 | $816 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,820 | -8,314 | -7,742 | -4,367 | -509 |
| Capital Expenditure | -307 | -704 | -1,199 | -24 | N/A |
| Free Cash Flow | -8,127 | -9,018 | -8,941 | -4,391 | -509 |